43 related articles for article (PubMed ID: 38677720)
21. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals.
Corma-Gómez A; Macías J; Téllez F; Freyre-Carrillo C; Morano L; Rivero-Juárez A; Ríos MJ; Alados JC; Vera-Méndez FJ; Merchante N; Palacios R; Granados R; Merino D; De Los Santos I; Pineda JA
Clin Infect Dis; 2020 Dec; 71(9):2354-2362. PubMed ID: 31754695
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological Modulation of the Wnt/β-Catenin Pathway Inhibits Proliferation and Promotes Differentiation of Long-Lived Memory CD4
Mavigner M; Zanoni M; Tharp GK; Habib J; Mattingly CR; Lichterfeld M; Nega MT; Vanderford TH; Bosinger SE; Chahroudi A
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619550
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
Akcora BÖ; Storm G; Bansal R
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients.
Navarro J; Laguno M; Vilchez HH; Guardiola JM; Carrion JA; Force L; Cairó M; Cifuentes C; Vilaró J; Cucurull J; Marco A; Roget M; Erice E; Crespo M;
J Antimicrob Chemother; 2017 Oct; 72(10):2850-2856. PubMed ID: 29091196
[TBL] [Abstract][Full Text] [Related]
25. Long-term liver stiffness assessment in hepatitis C virus patients undergoing antiviral therapy: Results from a 5-year cohort study.
Facciorusso A; Del Prete V; Turco A; Buccino RV; Nacchiero MC; Muscatiello N
J Gastroenterol Hepatol; 2018 Apr; 33(4):942-949. PubMed ID: 28976021
[TBL] [Abstract][Full Text] [Related]
26. Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial.
Kimura K; Ikoma A; Shibakawa M; Shimoda S; Harada K; Saio M; Imamura J; Osawa Y; Kimura M; Nishikawa K; Okusaka T; Morita S; Inoue K; Kanto T; Todaka K; Nakanishi Y; Kohara M; Mizokami M
EBioMedicine; 2017 Sep; 23():79-87. PubMed ID: 28844410
[TBL] [Abstract][Full Text] [Related]
27. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.
Liepelt A; Tacke F
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G203-9. PubMed ID: 27313175
[TBL] [Abstract][Full Text] [Related]
28. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.
Konerman MA; Mehta SH; Sutcliffe CG; Vu T; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS
Hepatology; 2014 Mar; 59(3):767-75. PubMed ID: 24436062
[TBL] [Abstract][Full Text] [Related]
29. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.
Pérez-Latorre L; Sánchez-Conde M; Rincón D; Miralles P; Aldámiz-Echevarría T; Carrero A; Tejerina F; Díez C; Bellón JM; Bañares R; Berenguer J
Clin Infect Dis; 2014 Mar; 58(5):713-8. PubMed ID: 24265358
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive markers for hepatic fibrosis.
Baranova A; Lal P; Birerdinc A; Younossi ZM
BMC Gastroenterol; 2011 Aug; 11():91. PubMed ID: 21849046
[TBL] [Abstract][Full Text] [Related]
31. Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis.
Ingiliz P; Valantin MA; Preziosi P; Finzi L; Pais R; Fedchuk L; Dominguez S; Katlama C; Poynard T; Benhamou Y
J Hepatol; 2012 Jan; 56(1):49-54. PubMed ID: 21781946
[TBL] [Abstract][Full Text] [Related]
32. Increasing burden of liver disease in patients with HIV infection.
Joshi D; O'Grady J; Dieterich D; Gazzard B; Agarwal K
Lancet; 2011 Apr; 377(9772):1198-209. PubMed ID: 21459211
[TBL] [Abstract][Full Text] [Related]
33. Current status of Japanese HIV-infected patients with coagulation disorders: coinfection with both HIV and HCV.
Tatsunami S; Mimaya J; Shirahata A; Zelinka J; Horová I; Hanai J; Nishina Y; Ohira K; Taki M
Int J Hematol; 2008 Oct; 88(3):304-310. PubMed ID: 18677450
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive evaluation of liver fibrosis using transient elastography.
Castera L; Forns X; Alberti A
J Hepatol; 2008 May; 48(5):835-47. PubMed ID: 18334275
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients.
de Lédinghen V; Douvin C; Kettaneh A; Ziol M; Roulot D; Marcellin P; Dhumeaux D; Beaugrand M
J Acquir Immune Defic Syndr; 2006 Feb; 41(2):175-9. PubMed ID: 16394849
[TBL] [Abstract][Full Text] [Related]
36. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.
Merchante N; Girón-González JA; González-Serrano M; Torre-Cisneros J; García-García JA; Arizcorreta A; Ruiz-Morales J; Cano-Lliteras P; Lozano F; Martínez-Sierra C; Macías J; Pineda JA;
AIDS; 2006 Jan; 20(1):49-57. PubMed ID: 16327319
[TBL] [Abstract][Full Text] [Related]
37. Safety and tolerability of OP-724 in patients with haemophilia and liver cirrhosis due to HIV/HCV coinfection: an investigator-initiated, open-label, non-randomised, single-centre, phase I study.
Kimura K; Tanuma J; Kimura M; Imamura J; Yanase M; Ieiri I; Kurosaki M; Watanabe T; Endo T; Yotsuyanagi H; Gatanaga H
BMJ Open Gastroenterol; 2024 Apr; 11(1):. PubMed ID: 38677720
[TBL] [Abstract][Full Text] [Related]
38. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.
Falade-Nwulia O; Suarez-Cuervo C; Nelson DR; Fried MW; Segal JB; Sulkowski MS
Ann Intern Med; 2017 May; 166(9):637-648. PubMed ID: 28319996
[TBL] [Abstract][Full Text] [Related]
39. Use of transient elastography in patients with HIV-HCV coinfection: A systematic review and meta-analysis.
Njei B; McCarty TR; Luk J; Ewelukwa O; Ditah I; Lim JK
J Gastroenterol Hepatol; 2016 Oct; 31(10):1684-1693. PubMed ID: 26952020
[TBL] [Abstract][Full Text] [Related]
40. HIV/hepatitis C coinfection natural history and disease progression.
Hernandez MD; Sherman KE
Curr Opin HIV AIDS; 2011 Nov; 6(6):478-82. PubMed ID: 22001892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
